top of page

#xenotransplantation #COVIDvaccine #CervicalCancer


#Doctor, could you comment on these topics to the #media today?


>> Second try at an unusual operation

>> Why you can’t find a COVID shot

>> An advance in cervical cancer treatment


The Med & Mic™ 10.23.23

A medical news blog post



Second Ever Pig Heart Transplantation

A heart from a genetically modified pig is functioning without signs of rejection one month after transplant into a human. The experimental surgery occurred in September at the University of Maryland. Because the heart is functioning on its own, the care team is withdrawing medications. The 58-year-old recipient had end stage heart disease and other medical conditions that made him ineligible for a human heart. He consented to the treatment and was informed of the risks. He had a full psychiatric evaluation and met with a medical ethicist. Because he has had a month-long hospital stay, he is undergoing physical therapy to increase his strength. The first recipient of a pig-to-human heart transplant died two months after surgery. (Source: CNN, N. Kounang, 10.20.23)



New COVID Vaccines Hard to Find

Fewer pharmacy appointments and hospitals and clinics without shipments have made it difficult for people to find the newest iteration of the COVID vaccine. During the pandemic, the government was paying for supply and distribution. Now that the public health emergency is over, wholesalers and distributors, pharmacies, and insurance companies are playing a role in the new vaccine infrastructure. (Source: USA Today, A. Rodriguez, 10.23.23)



Study: A New Treatment Regimen for Cervical Cancer

A combination of inexpensive, existing drugs prior to radiation treatment cuts the risk of death from cervical cancer by 35%. The study findings were announced at the European Society for Medical Oncology. In the study, 250 women received carboplatin and paclitaxel, radiotherapy, and weekly cisplatin and brachytherapy. Another 250 women received standard treatment. At five years, 80% of those who received the new regimen were alive, and in 73% the cancer did not return or spread. The lead investigator says this is the biggest improvement in outcome in over 20 years. Typically, cervical cancer recurs in one in three cases. (Source: BBC News, M. Roberts, 10.23.23)

 

Click the follow button to keep up on the medical news of the day.

P.S. For more about preparing for media interviews, read “Scoop, MD: the Doctor’s Guide to Media Interviews and Opportunities” on Amazon Kindle Vella.


Remember: this post is for informational purposes only and may not be the best fit for you and your personal situation. It shall not be construed as medical advice. The information and education provided here is not intended or implied to supplement or replace professional medical treatment, advice, and/or diagnosis, or the advice of your own physician. Always check with your own physician or medical professional before trying or implementing any information read here.


10 views0 comments

Commenti


Post: Blog2_Post
bottom of page